Cipher Pharmaceuticals Schedules Q4 2022 Earnings Release and Conference Call
March 10 2023 - 5:30PM
PR Newswire (Canada)
MISSISSAUGA, ON, March 10,
2023 /CNW/ - Cipher Pharmaceuticals Inc. (TSX:
CPH) ("Cipher" or "the Company") today announced that
it will release its financial results for the three and twelve
months ended December 31, 2022 after
market close on March 16, 2023. The
Company will also host a conference call on Friday, March 17, 2023 at 8:30am ET to discuss the results and corporate
developments.
CONFERENCE CALL DETAILS
DATE:
|
Friday, March 17,
2023
|
TIME:
|
8:30 a.m.
EDT
|
DIAL-IN NUMBER:
|
(416) 764-8650 or (888)
664-6383
|
CONFERENCE ID:
|
02194569
|
REPLAY DIAL-IN:
|
(888) 390-0541
(playback 194569#)
|
|
Expires March 24,
2023
|
WEBCAST:
|
https://app.webinar.net/VDZxNRGzWPq
|
About Cipher Pharmaceuticals
Inc.
Cipher Pharmaceuticals (TSX: CPH) is a specialty pharmaceutical
company with a robust and diversified portfolio of commercial and
early to late-stage products. Cipher acquires products that fulfill
unmet medical needs, manages the required clinical development and
regulatory approval process, and currently markets those products
either directly in Canada or
indirectly through partners in Canada, the U.S., and South America. For more information, visit
www.cipherpharma.com.
SOURCE Cipher Pharmaceuticals Inc.
Copyright 2023 Canada NewsWire
Cipher Pharmaceuticals (TSX:CPH)
Historical Stock Chart
From Mar 2024 to Apr 2024
Cipher Pharmaceuticals (TSX:CPH)
Historical Stock Chart
From Apr 2023 to Apr 2024